What is a NuShield?

What is a NuShield?

NuShield is the most complete, shelf-stable, dehydrated placental allograft barrier that supports an environment for healing with its unique preservation method.

What is NuShield made of?

NuShield consists of the complete amnion and chorion layers of the placental membrane.

What does the organogenesis do?

Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets.

What is a placental allograft?

These placental allografts are naturally derived tissues composed of cells, extracellular matrix (ECM) and a complex array of regulatory cytokines with the inherent function of supporting tissue growth and modulating inflammation.

Is NuShield FDA approved?

NuShield® is a sterile, dehydrated placental allograft, consisting of amnion and chorion membranes, processed by DCI Donor Services (DCIDS) Tissue Bank from donated amniotic-derived human tissue. DCIDS Tissue Bank is a full service not-for-profit tissue bank accredited by AATB and registered with FDA.

How does dermagraft work?

Dermagraft delivers a collagen-rich living human dermal matrix to the prepared ulcer wound bed. Metabolically active fibroblasts are distributed throughout the Dermagraft and retain the capacity for secreting a variety of regulatory and structural proteins.

How long does organogenesis last?

Of the four phases, organogenesis occurs over the longest period of time, extending from about four weeks of development (during the period of the embryo), throughout the fetal period, and for some organ systems even continuing postnatally.

Where does amnion skin graft come from?

Amniotic membrane is tissue obtained from human placenta rich in cytokines, growth factors, and stem cells that possess the ability to inhibit infection, improve healing, and stimulate regeneration.

What is a derma graft?

Dermagraft® is a sterile, cryopreserved, human fibroblast–derived dermal substitute generated by the culture of neonatal dermal fibroblasts onto a bioabsorbable polyglactin mesh scaffold.